TristelTSNLF +6.35%97 FCF Margin % is 18.02% as of Dec. 2025, which is 11% above its 10-year median of 16.18. GuruFocus rates TSNLF with a GF Score™ of 97/100 and a GF Value™ of $6.13 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Tristel ranks better than 88.71% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tristel's Free Cash Flow for the
six
months ended in Dec. 2025 was $6.19 Mil. Tristel's Revenue for the
six
months ended in Dec. 2025 was $34.34 Mil. Therefore, Tristel's FCF Margin % for the quarter that ended in Dec. 2025 was 18.02%.
The historical rank and industry rank for Tristel's FCF Margin % or its related term are showing as below:
TSNLF'
s FCF Margin % Range Over the Past 10 Years
Min: 13.42 Med: 16.18 Max: 21.31
Current: 18.21
During the past 13 years, the highest FCF Margin % of Tristel was 21.31%. The lowest was 13.42%. And the median was 16.18%.
TSNLF's FCF Margin % is ranked better than 88.71% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs TSNLF: 18.21
Tristel FCF Margin % Related Terms
Tristel FCF Margin % Historical Data
* Premium members only.
The historical data trend for Tristel's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tristel's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tristel FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tristel's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Tristel's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tristel (TSNLF) has a FCF Margin % of 18.02% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tristel and its competitors. This is 11% above median its historical median of 16.18. Over the past decade, Tristel's FCF Margin % has ranged from 13.42 to 21.31. According to the industry distribution chart, Tristel ranks #92 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 11.3%.
Is Tristel's FCF Margin % too high?
Tristel's current FCF Margin % of 18.02% is 11% above median its 10-year median of 16.18. Over the past 10 years, this metric has ranged from a low of 13.42 to a high of 21.31. Based on the distribution chart, Tristel ranks #92 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tristel has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tristel's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tristel ranks #92 out of 815 companies for FCF Margin %. This places Tristel in the top 11% of its industry — outperforming the majority of peers. Historically, Tristel's own FCF Margin % has ranged from 13.42 to 21.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tristel and its competitors. Tristel's current FCF Margin % is 18.02%, which is 11% above median its own 10-year median of 16.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.13, compared to a current price of $5.53 — trading 9.8% below its estimated fair value. The current FCF Margin % is 18.02%, which is 11% above median its 10-year median of 16.18. Tristel's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tristel (TSNLF), the current FCF Margin % is 18.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tristel (TSNLF) Overvalued in 2026?
Based on GuruFocus' analysis, Tristel stock appears to be undervalued.
The current stock price of $5.53 is trading 9.8% below its estimated GF Value™ of $6.13.
GuruFocus considers Tristel to be Modestly Undervalued.
Key valuation signals for TSNLF:
FCF Margin %: 18.02% (11% above median its 10-year median of 16.18)
GF Value™: $6.13 vs. price of $5.53 (9.8% below fair value)
No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
97GF Score
Get the complete analysis for TSNLF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSNLF has been successfully added to your 
